SCM

Sio Capital Management Portfolio holdings

AUM $249M
This Quarter Return
-7.2%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$310M
AUM Growth
+$310M
Cap. Flow
-$32.1M
Cap. Flow %
-10.36%
Top 10 Hldgs %
50.58%
Holding
85
New
10
Increased
22
Reduced
16
Closed
22

Top Buys

1
GLPG icon
Galapagos
GLPG
$11.8M
2
CI icon
Cigna
CI
$10.2M
3
MRK icon
Merck
MRK
$9.39M
4
CAH icon
Cardinal Health
CAH
$5.32M
5
RCOR
Renovacor, Inc.
RCOR
$4.85M

Top Sells

1
HRC
HILL-ROM HOLDINGS, INC.
HRC
$8.71M
2
AMGN icon
Amgen
AMGN
$8.53M
3
AFMD
Affimed
AFMD
$6.07M
4
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
$5.72M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
$5.6M

Sector Composition

1 Healthcare 89.71%
2 Consumer Staples 2.95%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SYRS
26
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.03M 1.28%
90,068
+10,068
+13% +$450K
SPRB
27
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$3.62M 1.16%
603,027
-44,212
-7% -$266K
AYLA
28
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$3.61M 1.15%
318,599
-224,378
-41% -$2.54M
SYRE icon
29
Spyre Therapeutics
SYRE
$1.02B
$3.55M 1.13%
17,840
+1,734
+11% +$345K
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$710M
$3.32M 1.06%
91,362
+8,390
+10% +$305K
NBSE
31
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3.27M 1.04%
45,322
+1,887
+4% +$136K
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.21M 1.02%
29,319
-38,152
-57% -$4.18M
MBRX icon
33
Moleculin Biotech
MBRX
$11.3M
$3.12M 1%
69,369
+2,379
+4% +$107K
RDUS
34
DELISTED
Radius Health, Inc.
RDUS
$3M 0.96%
241,905
+948
+0.4% +$11.8K
DTIL icon
35
Precision BioSciences
DTIL
$59.5M
$2.97M 0.95%
8,572
-1,209
-12% -$419K
GYRE icon
36
Gyre Therapeutics
GYRE
$734M
$2.56M 0.82%
83,186
– –
EUCRU
37
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2.47M 0.79%
248,674
-51,326
-17% -$511K
OBIO icon
38
Orchestra BioMed
OBIO
$147M
$2.47M 0.79%
250,000
– –
ASLN
39
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$2.26M 0.72%
31,769
-5,444
-15% -$388K
CYCC icon
40
Cyclacel Pharmaceuticals
CYCC
$17.2M
$2.23M 0.71%
117
+1
+0.9% +$19K
SRRA
41
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.09M 0.67%
95,450
+2,198
+2% +$48.2K
FUSN
42
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.06M 0.66%
259,763
-6,344
-2% -$50.2K
CBAY
43
DELISTED
Cymabay Therapeutics
CBAY
$2.05M 0.65%
562,339
– –
LPTX icon
44
Leap Therapeutics
LPTX
$12M
$1.76M 0.56%
+44,000
New +$1.76M
VINC
45
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.65M 0.53%
5,102
-1,944
-28% -$629K
PTGX icon
46
Protagonist Therapeutics
PTGX
$3.62B
$1.6M 0.51%
+90,000
New +$1.6M
SLRX icon
47
Salarius Pharmaceuticals
SLRX
$2.45M
$1.38M 0.44%
451
– –
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.29M 0.41%
21,738
– –
MEIP icon
49
MEI Pharma
MEIP
$149M
$1.18M 0.37%
21,302
– –
NTUS
50
DELISTED
Natus Medical Inc
NTUS
$987K 0.31%
+39,354
New +$987K
1
2
3 4